Immuno-Oncology 360°

Scheduled For: Wednesday, February 7th, 2018 View all Events

Date: February 7-9, 2018
Website: Immuno-Oncology 360°
Location: New York City, NY







Neoantigen Approaches for Biomarkers

Daniel Duncan, M.D. | Medical Director and Director, Translational NGS

February 8, 2018 | 1:25 pm EST

This talk will include data that demonstrates how Cancer Genetics leveraged NGS with advanced computational analysis to identify novel expressed mutations and algorithmically estimate the binding affinity of the translated protein to the major histocompatibility complex haplotypes encoded by each genome.  Their IO Complete workflow can be utilized to both characterize overall somatic mutation burden and neoantigen burden, and validate predicted epitopes as a precursor to designing novel therapeutic agents.

[formidable id=12 title=true description=true]